or
Remember me
Back
Fourth Quarter 2021 Financial Highlights
Comparisons are to the three months ended December 31, 2020.
Net revenue of $296.5 million, up 0.9% compared to $293.8 million
Net Income of $17.0 million, or $0.44 per diluted share, down 34.5% from $25.9 million
Adjusted EBITDA of $58.4 million, down 8.8% compared to $64.1 million
Adjusted EBITDA less Patient Equipment Capex of $28.3 million, down 19.1% from $34.9 million
A daily snapshot of everything from market open to close.